U1
U1, licence 80085525: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Ewyn Studios International
- NPN or DIN-HM
- 80085525
- Status
- Active licence
- Licence date
- 25 May 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Substance interdite
Contains the plant Garcinia cambogia (Garcinia gummi-gutta). In France, importing and placing food supplements containing it on the market are suspended until 17 April 2027 (arrêté du 16 avril 2026).
arrêté du 16 avril 2026 (JORFTEXT000053907152). French orders suspending food supplements containing a plant (Official Journal), checked against the text, retrieved 23 October 2026.
Order published in the French Official Journal, read on Légifrance.
- Dose déclarée au-delà d'une limite
Chrome: up to 75 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 25 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Chrome Source : Picolinate de chrome (III) | 12.5 mcg | 75 µg |
| Rhodiola rosea Source : Racine et rhizome Potency : 3.0 % Rosavins | Not specified | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 12.0:1.0 Dry plant equivalent : 150.0 mg Potency : 85.0 % Proanthocyanidins | 12.5 mg | Not calculated |
| Rhodiola rosea Source : Racine et rhizome Potency : 2.0 % Salidroside | 15.0 mg | Not calculated |
| Poly-bêta-(1,4)-2-amino-2-désoxy-d-glucose Source : Chitine | 10.0 mg | Not calculated |
| Extrait de haricot blanc Source : Phaseolus vulgaris - Graine Extract : Matériel brut sec Extraction ratio : 5.0:1.0 Dry plant equivalent : 125.0 mg | 25.0 mg | Not calculated |
| Garcinia gummi-gutta Source : Pelure (fruit) Potency : 60.0 % Hydroxycitric acid | 47.5 mg | Not calculated |
| Zingiber officinale Source : Rhizome Potency : 20.0 % Total gingerols | 25.0 mg | Not calculated |
| L-Carnitine Source : L-tartrate de carnitine | 200.0 mg | Not calculated |
| Cinnamomum aromaticum Source : Ecorce (tronc) Extract : Matériel brut sec Extraction ratio : 4.0:1.0 Dry plant equivalent : 100.0 mg | 25.0 mg | Not calculated |
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Astaxanthin | 1.65 mg | Not calculated |
| 3,3'-dihydroxy-4,4'-diketo-bêta-carotène Source : Haematococcus pluvialis - whole | 1.65 mg | Not calculated |
| trans-Resvératrol Source : Resvératrol | 12.5 mg | Not calculated |
| trans-Resvératrol Source : Reynoutria Japonica - racine | 12.5 mg | Not calculated |
Non-medicinal ingredients
Gélatine, Cétone de framboise, Safranal, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | 3.0 Jour(s) |
Uses authorised in Canada
Text supplied in English because no French text is available.
Aids in the muscle recovery process by reducing muscle tissue damage associated with a resistance training regimen. Helps support muscle tissue repair in individuals involved in resistance training. Helps support fat oxidation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80085525
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.